Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Contracts + Grants

    NIH Awards $3M Grant to Albany Med for Plague Vaccine Development

    By Global Biodefense StaffApril 8, 2022
    Yersinia pestis
    Scanning electron micrograph of Yersinia pestis, which causes bubonic plague, on proventricular spines of a Xenopsylla cheopis flea. Credit: NIAID
    Share
    Facebook LinkedIn Reddit Email

    Albany Medical College scientists have been awarded a $3 million, five-year federal grant to develop a vaccine that could protect against plague.

    The funding is from the the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

    A highly contagious disease caused by the bacteria Yersinia pestis (Y. pestis), plague has killed millions of people throughout history. Bubonic plague is the most common naturally occurring form of the three main types of plague, which also include pneumonic plague and septicemic plague. In the U.S., plague is most common in rural areas of the southwest, particularly New Mexico, Arizona and Colorado.

    For the most part, plague today is treated with antibiotics; there is no vaccine currently available that provides long-term defense against it.

    “While plague in humans is relatively rare, we’ve begun to see strains that are resistant to antibiotics and there are concerns it could be used as a bioweapon,” explained Wei Sun, Ph.D., associate professor in the Department of Immunology and Microbial Disease at Albany Medical College, who is leading the study.

    Dr. Sun and his team will attempt to modify another, less-lethal bacteria in the Yersinia family – Y. pseudotuberculosis (Yptb) – into a carrier for protective antigens against Y. pestis. After testing the protective immunity of this strain in animal models, they’ll work to decipher the mechanisms of the immune protection it induces

    “Our hope is that this project provides the fundamentals for the development of a highly effective and safe vaccine that can protect against current and future strains of plague,” said Dr. Sun.

    RELATED RESEARCH:

    Remodeling Yersinia pseudotuberculosis to generate a highly immunogenic outer membrane vesicle vaccine against pneumonic plague. PNAS, 11 March 2022.

    Hemochromatosis drives acute lethal intestinal responses to hyperyersiniabactin-producing Yersinia pseudotuberculosis. PNAS, 30 Dec 2021

    Recombinant Pseudomonas Bionanoparticles Induce Protection against Pneumonic Pseudomonas aeruginosa Infection. Infection and Immunity, 15 October 2021.

    Dissecting the psa locus regulation in Yersinia pestis. Journal of Bacteriology, 8 September 2021.

     Oral vaccination with live attenuated Yersinia pseudotuberculosis strains delivering a FliC180-LcrV fusion antigen confers protection against pulmonary Y. pestis infection. Vaccine, 6 May 2020

    Awards Editor Pick NIAID Select Agents Vaccine News Y. pestis
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleBird Flu is Killing Millions of Chickens and Turkeys Across the US
    Next Article NIAID Funding Available for Biocontainment Facility Improvements

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic Pathogens

    September 24, 2023

    Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease

    September 24, 2023

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.